Opioid Antagonist [EPC]

Opioid Antagonist [EPC] was reported 961 times

Drugs of the Opioid Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ABSTAINS FROM RECREATIONAL DRUGS 1 0.3333
1 THERMOPHOBIA 1 0.0526
2 NEUROSTIMULATOR REMOVAL 1 0.0417
3 NEONATAL COMPLICATIONS OF SUBSTANCE ABUSE 1 0.0385
4 DISSEMINATED GONOCOCCAL INFECTION 1 0.0370
5 DRUG DEPENDENCE, ANTEPARTUM 1 0.0192
6 MISCARRIAGE OF PARTNER 1 0.0182
7 TONSILLAR ERYTHEMA 1 0.0152
8 PRODUCT DOSAGE FORM ISSUE 7 0.0145
9 LOOSE ASSOCIATIONS 1 0.0139
10 ANTICHOLINERGIC EFFECT 1 0.0133
11 EYELID MYOCLONUS 1 0.0100
12 GLOMERULONEPHRITIS ACUTE 2 0.0097
13 PILOERECTION 10 0.0091
14 RHESUS INCOMPATIBILITY 1 0.0083
15 PRODUCT SOLUBILITY ABNORMAL 36 0.0071
16 DRUG WITHDRAWAL MAINTENANCE THERAPY 1 0.0071
17 HETEROPHORIA 1 0.0069
18 RESTLESS ARM SYNDROME 1 0.0064
19 INFECTIVE GLOSSITIS 1 0.0064
20 NEPHROANGIOSCLEROSIS 1 0.0062
21 SCROTAL ERYTHEMA 1 0.0060
22 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
23 TOOTH HYPOPLASIA 1 0.0057
24 GLOMERULONEPHRITIS CHRONIC 1 0.0053
25 STREPTOCOCCAL URINARY TRACT INFECTION 1 0.0052
26 CORTISOL ABNORMAL 1 0.0050
27 SYMPATHOMIMETIC EFFECT 1 0.0043
28 ANORECTAL OPERATION 1 0.0042
29 OPIATES POSITIVE 2 0.0042
30 CHILD NEGLECT 1 0.0041
31 PURPURA FULMINANS 1 0.0039
32 CHILD ABUSE 1 0.0039
33 CYANOSIS CENTRAL 1 0.0038
34 PATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0037
35 INFUSION SITE THROMBOSIS 1 0.0037
36 EAR INFECTION BACTERIAL 1 0.0037
37 SUSPECTED PRODUCT TAMPERING 2 0.0036
38 IRREGULAR BREATHING 2 0.0034
39 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 1 0.0032
40 INCREASED DOSE ADMINISTERED 1 0.0032
41 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
42 YAWNING 8 0.0030
43 FOETAL HYPOKINESIA 2 0.0029
44 ANDROGEN DEFICIENCY 1 0.0028
45 RADIAL NERVE PALSY 1 0.0028
46 CRYOGLOBULINAEMIA 2 0.0028
47 PRODUCT TAMPERING 5 0.0028
48 CEREBRAL MASS EFFECT 1 0.0028
49 ANKLE ARTHROPLASTY 1 0.0028
50 MULTIPLE DRUG THERAPY 2 0.0027
51 JAUNDICE NEONATAL 5 0.0026
52 ACUTE PHASE REACTION 1 0.0026
53 CEREBELLAR STROKE 1 0.0026
54 HYPERTENSIVE EMERGENCY 3 0.0025
55 DROPPED HEAD SYNDROME 1 0.0025
56 SINONASAL OBSTRUCTION 1 0.0025
57 SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY 1 0.0025
58 BASAL GANGLIA HAEMORRHAGE 2 0.0025
59 TOOTH EROSION 3 0.0024
60 DRUG WITHDRAWAL HEADACHE 1 0.0024
61 SPINAL DECOMPRESSION 1 0.0024
62 GLUCOCORTICOID DEFICIENCY 1 0.0024
63 GINGIVAL BLISTER 1 0.0023
64 HOMELESS 1 0.0022
65 MANUFACTURING ISSUE 1 0.0022
66 PIGMENTARY MACULOPATHY 1 0.0021
67 MYELOID LEUKAEMIA 1 0.0020
68 DENTAL CARIES 22 0.0020
69 SALIVARY GLAND ENLARGEMENT 1 0.0019
70 INFUSION SITE CELLULITIS 1 0.0019
71 NON-CARDIOGENIC PULMONARY OEDEMA 2 0.0019
72 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
73 SCROTAL PAIN 1 0.0019
74 HYPERTENSIVE URGENCY 1 0.0018
75 DRUG EFFECT VARIABLE 2 0.0018
76 BURN ORAL CAVITY 1 0.0017
77 THOUGHT BLOCKING 1 0.0017
78 BLOOD OESTROGEN INCREASED 1 0.0017
79 NEURODEGENERATIVE DISORDER 1 0.0016
80 DRUG DIVERSION 10 0.0016
81 ELBOW OPERATION 1 0.0016
82 BLADDER DISCOMFORT 2 0.0016
83 BREECH PRESENTATION 2 0.0016
84 ANION GAP 1 0.0016
85 SKULL MALFORMATION 1 0.0016
86 ENTEROCOCCUS TEST POSITIVE 1 0.0015
87 GINGIVAL DISCOMFORT 1 0.0015
88 POTENTIATING DRUG INTERACTION 5 0.0015
89 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 10 0.0015
90 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
91 CARDIAC SEPTAL DEFECT 1 0.0014
92 NASAL INJURY 1 0.0014
93 DENTAL RESTORATION FAILURE 1 0.0014
94 BLUNTED AFFECT 1 0.0014
95 AMPHETAMINES POSITIVE 1 0.0013
96 MICTURITION FREQUENCY DECREASED 1 0.0013
97 INJECTION SITE REACTION 91 0.0013
98 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
99 WITHDRAWAL SYNDROME 53 0.0013
100 RESPIRATORY DISORDER NEONATAL 2 0.0012
101 TONGUE ERYTHEMA 1 0.0012
102 STARVATION 1 0.0012
103 COVID-19 IMMUNISATION 1 0.0012
104 INFECTED BITE 1 0.0012
105 DEVICE LOOSENING 1 0.0012
106 VASOCONSTRICTION 1 0.0011
107 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
108 ACUTE CHEST SYNDROME 1 0.0011
109 DRUG SCREEN NEGATIVE 2 0.0011
110 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 7 0.0011
111 DRUG DETOXIFICATION 1 0.0011
112 CLONUS 3 0.0011
113 PRODUCT APPEARANCE CONFUSION 1 0.0011
114 PHARYNGEAL HYPOAESTHESIA 1 0.0011
115 ORAL ADMINISTRATION COMPLICATION 1 0.0011
116 PRODUCT AFTER TASTE 1 0.0010
117 GINGIVAL DISORDER 4 0.0010
118 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
119 DILATED CARDIOMYOPATHY 1 0.0010
120 HYPOGONADISM 1 0.0010
121 AUTONOMIC NEUROPATHY 1 0.0010
122 PRODUCT SUBSTITUTION ISSUE 56 0.0010
123 NON-ALCOHOLIC STEATOHEPATITIS 1 0.0010
124 DRUG USE DISORDER 8 0.0010
125 OEDEMA MUCOSAL 1 0.0010
126 SINUSITIS BACTERIAL 1 0.0009
127 FOETAL DISTRESS SYNDROME 2 0.0009
128 PRODUCT COMMINGLING 1 0.0009
129 NEUROMYOPATHY 1 0.0009
130 GALLBLADDER ENLARGEMENT 1 0.0009
131 PRODUCT NAME CONFUSION 1 0.0009
132 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 1 0.0009
133 TONGUE BLISTERING 2 0.0009
134 CLEFT LIP AND PALATE 1 0.0009
135 DRUG WITHDRAWAL SYNDROME 78 0.0009
136 HALO VISION 1 0.0009
137 ADMINISTRATION SITE PAIN 1 0.0009
138 REACTION TO EXCIPIENT 2 0.0009
139 HYPERREFLEXIA 3 0.0009
140 GLOSSITIS 3 0.0008
141 FEBRILE CONVULSION 1 0.0008
142 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0008
143 RENAL ATROPHY 1 0.0008
144 HYPERAESTHESIA TEETH 1 0.0008
145 TESTICULAR SWELLING 1 0.0008
146 ENDODONTIC PROCEDURE 2 0.0008
147 INFUSION SITE IRRITATION 1 0.0008
148 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
149 ORAL INFECTION 3 0.0008
150 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
151 SUBSTANCE ABUSE 6 0.0007
152 DRUG SCREEN FALSE POSITIVE 2 0.0007
153 PERIODONTAL DISEASE 1 0.0007
154 RENAL TUBULAR DISORDER 2 0.0007
155 CATAPLEXY 1 0.0007
156 CONNECTIVE TISSUE DISORDER 1 0.0007
157 STRESS CARDIOMYOPATHY 4 0.0007
158 INTENTIONAL UNDERDOSE 5 0.0007
159 ACUTE ABDOMEN 1 0.0007
160 SEROTONIN SYNDROME 13 0.0007
161 DRUG WITHDRAWAL SYNDROME NEONATAL 10 0.0007
162 TOOTH LOSS 14 0.0007
163 INFUSION SITE INDURATION 1 0.0007
164 IMPETIGO 1 0.0007
165 CARDIO-RESPIRATORY ARREST 28 0.0007
166 DRUG ABUSE 55 0.0007
167 ORAL MUCOSAL ERUPTION 1 0.0007
168 ORAL MUCOSAL ERYTHEMA 1 0.0006
169 SUBSTANCE USE 1 0.0006
170 ONYCHOLYSIS 1 0.0006
171 TRANSCRIPTION MEDICATION ERROR 1 0.0006
172 TOOTH FRACTURE 7 0.0006
173 EXPOSURE TO TOXIC AGENT 2 0.0006
174 NEAR DEATH EXPERIENCE 2 0.0006
175 SEBORRHOEIC DERMATITIS 1 0.0006
176 VEIN RUPTURE 1 0.0006
177 RECTAL ABSCESS 1 0.0006
178 TONSILLAR HYPERTROPHY 1 0.0006
179 COLITIS ISCHAEMIC 4 0.0006
180 CEREBELLAR INFARCTION 1 0.0006
181 PRIAPISM 2 0.0006
182 TONGUE COATED 1 0.0006
183 ORAL DISCOMFORT 8 0.0006
184 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
185 HYPOPITUITARISM 1 0.0006
186 INFUSION SITE DISCHARGE 1 0.0006
187 HANGOVER 2 0.0006
188 RENAL PAIN 6 0.0006
189 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
190 DEVICE ALARM ISSUE 1 0.0006
191 VENOUS OCCLUSION 1 0.0005
192 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
193 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
194 OESOPHAGEAL SPASM 1 0.0005
195 DISORGANISED SPEECH 1 0.0005
196 ACCIDENTAL DEATH 1 0.0005
197 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
198 INSURANCE ISSUE 8 0.0005
199 HYPOREFLEXIA 1 0.0005
200 GINGIVAL RECESSION 1 0.0005
201 CLEFT PALATE 1 0.0005
202 ALCOHOL INTERACTION 1 0.0005
203 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
204 THERAPY CHANGE 5 0.0005
205 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
206 PRODUCT DISPENSING ERROR 11 0.0005
207 EMPYEMA 1 0.0005
208 PERIPHERAL ISCHAEMIA 2 0.0005
209 TONGUE DISCOMFORT 2 0.0005
210 RESTLESSNESS 17 0.0005
211 TOOTH INJURY 2 0.0005
212 BIPOLAR DISORDER 5 0.0005
213 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
214 PRODUCT USE COMPLAINT 7 0.0004
215 WRONG PRODUCT ADMINISTERED 3 0.0004
216 RENAL COLIC 1 0.0004
217 VASCULAR DEVICE INFECTION 2 0.0004
218 RESTLESS LEGS SYNDROME 8 0.0004
219 PREMATURE DELIVERY 7 0.0004
220 DYSMORPHISM 1 0.0004
221 PRE-ECLAMPSIA 2 0.0004
222 URINE FLOW DECREASED 1 0.0004
223 PULSE ABNORMAL 1 0.0004
224 STARING 1 0.0004
225 WRONG DOSE 1 0.0004
226 PRODUCT PACKAGING CONFUSION 1 0.0004
227 RESPIRATORY DEPRESSION 5 0.0004
228 DENTAL OPERATION 1 0.0004
229 ACUTE PSYCHOSIS 1 0.0004
230 FEELING DRUNK 3 0.0004
231 SUFFOCATION FEELING 1 0.0004
232 HYPERPARATHYROIDISM SECONDARY 1 0.0004
233 TOXIC ENCEPHALOPATHY 2 0.0004
234 EUPHORIC MOOD 4 0.0004
235 DRUG TITRATION ERROR 1 0.0004
236 TOOTHACHE 7 0.0004
237 CATATONIA 2 0.0004
238 ALCOHOL POISONING 1 0.0004
239 LARYNGOSPASM 1 0.0004
240 PRODUCT TASTE ABNORMAL 5 0.0004
241 EAR CONGESTION 1 0.0004
242 CLUMSINESS 1 0.0004
243 ULCERATIVE KERATITIS 1 0.0004
244 FAECALOMA 2 0.0004
245 MENTAL STATUS CHANGES 10 0.0004
246 THERAPEUTIC RESPONSE DELAYED 1 0.0004
247 PSYCHOMOTOR RETARDATION 1 0.0004
248 INADEQUATE ANALGESIA 3 0.0004
249 EYELID MARGIN CRUSTING 1 0.0003
250 VOMITING PROJECTILE 1 0.0003
251 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
252 INFUSION SITE REACTION 1 0.0003
253 URINE ANALYSIS ABNORMAL 1 0.0003
254 HYPERHIDROSIS 43 0.0003
255 ANAL INCONTINENCE 3 0.0003
256 HYPERCAPNIA 1 0.0003
257 LOSS OF EMPLOYMENT 1 0.0003
258 RECTAL CANCER 1 0.0003
259 FIBROSIS 1 0.0003
260 MULTIPLE-DRUG RESISTANCE 1 0.0003
261 BLOOD CREATININE DECREASED 1 0.0003
262 DELIRIUM 11 0.0003
263 NON-CARDIAC CHEST PAIN 1 0.0003
264 THERAPEUTIC RESPONSE CHANGED 2 0.0003
265 MYDRIASIS 4 0.0003
266 HYPOVENTILATION 1 0.0003
267 INFUSION SITE HAEMORRHAGE 1 0.0003
268 TOOTH INFECTION 4 0.0003
269 PRODUCT FORMULATION ISSUE 2 0.0003
270 TONGUE ULCERATION 1 0.0003
271 TOXICITY TO VARIOUS AGENTS 49 0.0003
272 CERVICAL VERTEBRAL FRACTURE 1 0.0003
273 EXPOSURE DURING PREGNANCY 18 0.0003
274 HYPOPNOEA 1 0.0003
275 EXTRASYSTOLES 2 0.0003
276 THROMBOPHLEBITIS 1 0.0003
277 COLD SWEAT 5 0.0003
278 HAEMORRHAGIC DIATHESIS 1 0.0003
279 RHINORRHOEA 18 0.0003
280 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
281 TONGUE DISORDER 2 0.0003
282 COMPLETED SUICIDE 23 0.0003
283 MONOCYTE COUNT INCREASED 1 0.0003
284 ORAL DISORDER 2 0.0003
285 UNRESPONSIVE TO STIMULI 7 0.0003
286 CEREBRAL DISORDER 2 0.0003
287 PARANASAL SINUS DISCOMFORT 1 0.0003
288 CLAVICLE FRACTURE 1 0.0003
289 FAECES HARD 1 0.0003
290 CARDIOPULMONARY FAILURE 1 0.0003
291 BRAIN FOG 4 0.0003
292 TORSADE DE POINTES 2 0.0003
293 NAIL DISCOLOURATION 1 0.0003
294 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
295 RESPIRATORY ARREST 7 0.0003
296 EXPOSURE VIA BREAST MILK 1 0.0003
297 MIOSIS 2 0.0002
298 TRIGEMINAL NEURALGIA 1 0.0002
299 PRODUCT PHYSICAL ISSUE 5 0.0002
300 FUNGAL SKIN INFECTION 1 0.0002
301 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
302 SMALL INTESTINAL OBSTRUCTION 3 0.0002
303 ARTHRITIS BACTERIAL 1 0.0002
304 HYPERAESTHESIA 2 0.0002
305 SELF-MEDICATION 1 0.0002
306 LEG AMPUTATION 1 0.0002
307 EOSINOPHIL COUNT INCREASED 2 0.0002
308 HALLUCINATIONS, MIXED 1 0.0002
309 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
310 HALLUCINATION, VISUAL 5 0.0002
311 MUSCLE FATIGUE 1 0.0002
312 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
313 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
314 FACIAL PARALYSIS 2 0.0002
315 SHOULDER OPERATION 1 0.0002
316 ALCOHOLISM 1 0.0002
317 IMMOBILE 1 0.0002
318 TONGUE DISCOLOURATION 1 0.0002
319 GINGIVAL SWELLING 1 0.0002
320 ORAL PAIN 5 0.0002
321 SUSPECTED OFF LABEL USE 1 0.0002
322 URINE ABNORMALITY 1 0.0002
323 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
324 HIDRADENITIS 2 0.0002
325 IMMUNE THROMBOCYTOPENIA 1 0.0002
326 INCREASED TENDENCY TO BRUISE 2 0.0002
327 IRON DEFICIENCY ANAEMIA 2 0.0002
328 LOCALISED OEDEMA 1 0.0002
329 NEPHROGENIC ANAEMIA 1 0.0002
330 DEMENTIA 6 0.0002
331 THINKING ABNORMAL 4 0.0002
332 ROSACEA 1 0.0002
333 NEPHROPATHY 2 0.0002
334 SUSPECTED SUICIDE 1 0.0002
335 DRUG DEPENDENCE 34 0.0002
336 ENDOMETRIOSIS 1 0.0002
337 SLEEP APNOEA SYNDROME 4 0.0002
338 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
339 SUBCUTANEOUS ABSCESS 1 0.0002
340 PARAESTHESIA ORAL 3 0.0002
341 HUMERUS FRACTURE 1 0.0002
342 DRUG INTOLERANCE 20 0.0002
343 RASH VESICULAR 1 0.0002
344 INCORRECT DOSAGE ADMINISTERED 1 0.0002
345 APPLICATION SITE BURN 1 0.0002
346 PANCREATIC DISORDER 1 0.0002
347 SKIN HAEMORRHAGE 3 0.0002
348 HEPATIC ENZYME ABNORMAL 1 0.0002
349 FLUID INTAKE REDUCED 1 0.0002
350 TASTE DISORDER 4 0.0002
351 SUBARACHNOID HAEMORRHAGE 2 0.0002
352 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
353 ENDOCARDITIS 1 0.0002
354 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
355 TRISMUS 1 0.0002
356 RHABDOMYOLYSIS 8 0.0002
357 APLASTIC ANAEMIA 1 0.0002
358 CYANOSIS 3 0.0002
359 AGITATION 14 0.0002
360 SENSITIVITY TO WEATHER CHANGE 1 0.0002
361 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
362 ANAL FISTULA 1 0.0002
363 FOOD POISONING 1 0.0002
364 PRODUCT SIZE ISSUE 1 0.0002
365 BRUXISM 1 0.0002
366 GINGIVITIS 1 0.0002
367 BEHAVIOUR DISORDER 1 0.0002
368 PHARYNGITIS STREPTOCOCCAL 2 0.0002
369 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
370 SKIN LACERATION 2 0.0002
371 STOMATITIS 11 0.0002
372 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
373 FEELING COLD 5 0.0002
374 HEART RATE ABNORMAL 1 0.0002
375 MALNUTRITION 2 0.0002
376 SKIN INFECTION 2 0.0002
377 PRODUCT LEAKAGE 1 0.0002
378 INTESTINAL PERFORATION 2 0.0002
379 MUSCLE TWITCHING 4 0.0002
380 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
381 PRODUCT LABEL CONFUSION 1 0.0002
382 DECREASED INTEREST 1 0.0002
383 HEAD DISCOMFORT 3 0.0002
384 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 34 0.0002
385 ODYNOPHAGIA 1 0.0002
386 HEPATITIS C 2 0.0002
387 THERAPEUTIC RESPONSE DECREASED 10 0.0002
388 FIBROMYALGIA 4 0.0002
389 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
390 ACCIDENTAL OVERDOSE 6 0.0002
391 GENERALISED OEDEMA 2 0.0002
392 ILEUS 2 0.0002
393 TOOTH EXTRACTION 2 0.0002
394 INFUSION SITE EXTRAVASATION 1 0.0002
395 PRE-EXISTING CONDITION IMPROVED 1 0.0002
396 SWOLLEN TONGUE 5 0.0002
397 FEELING JITTERY 3 0.0002
398 ENTERITIS 1 0.0002
399 ILLNESS 16 0.0002
400 INFUSION SITE PAIN 2 0.0002
401 INJECTION SITE INDURATION 2 0.0002
402 HEPATITIS ACUTE 1 0.0002
403 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
404 PRODUCT PREPARATION ISSUE 1 0.0002
405 SOMNAMBULISM 1 0.0002
406 IMMUNE SYSTEM DISORDER 2 0.0002
407 ANXIETY 43 0.0002
408 POST-TRAUMATIC STRESS DISORDER 1 0.0001
409 QUALITY OF LIFE DECREASED 2 0.0001
410 ULCER HAEMORRHAGE 1 0.0001
411 DYSKINESIA 6 0.0001
412 TACHYPNOEA 2 0.0001
413 VOMITING 69 0.0001
414 ABNORMAL LOSS OF WEIGHT 1 0.0001
415 NAUSEA 116 0.0001
416 BLOOD TESTOSTERONE DECREASED 1 0.0001
417 EYE MOVEMENT DISORDER 1 0.0001
418 CHILLS 17 0.0001
419 TREATMENT FAILURE 12 0.0001
420 ENCEPHALITIS 1 0.0001
421 LARGE INTESTINE PERFORATION 1 0.0001
422 FORMICATION 1 0.0001
423 APPLICATION SITE REACTION 1 0.0001
424 DEVICE OCCLUSION 2 0.0001
425 SEASONAL ALLERGY 2 0.0001
426 THERMAL BURN 1 0.0001
427 RETCHING 3 0.0001
428 PRODUCT QUALITY ISSUE 19 0.0001
429 CARDIOGENIC SHOCK 2 0.0001
430 POOR QUALITY SLEEP 3 0.0001
431 IMPAIRED QUALITY OF LIFE 2 0.0001
432 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
433 RASH PUSTULAR 1 0.0001
434 APATHY 2 0.0001
435 MAJOR DEPRESSION 1 0.0001
436 BONE PAIN 8 0.0001
437 PSYCHIATRIC SYMPTOM 1 0.0001
438 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
439 TOOTH DISORDER 3 0.0001
440 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
441 SUNBURN 1 0.0001
442 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
443 GASTROINTESTINAL DISORDER 12 0.0001
444 IRRITABILITY 8 0.0001
445 TREMOR 22 0.0001
446 ECONOMIC PROBLEM 2 0.0001
447 HYPERTHERMIA 1 0.0001
448 OVERDOSE 28 0.0001
449 FOOD ALLERGY 1 0.0001
450 CONCUSSION 1 0.0001
451 THERAPY PARTIAL RESPONDER 2 0.0001
452 DRUG SCREEN POSITIVE 1 0.0001
453 LOW BIRTH WEIGHT BABY 1 0.0001
454 GINGIVAL PAIN 1 0.0001
455 UTERINE CANCER 1 0.0001
456 FRUSTRATION TOLERANCE DECREASED 1 0.0001
457 POST PROCEDURAL INFECTION 1 0.0001
458 POLYURIA 1 0.0001
459 HICCUPS 1 0.0001
460 MANIA 2 0.0001
461 EMBOLISM 1 0.0001
462 LIVE BIRTH 1 0.0001
463 ROAD TRAFFIC ACCIDENT 5 0.0001
464 INFUSION SITE ERYTHEMA 1 0.0001
465 HEMIPARESIS 2 0.0001
466 SKIN HYPERPIGMENTATION 1 0.0001
467 PARANOIA 2 0.0001
468 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
469 NAIL DISORDER 1 0.0001
470 INTENTIONAL PRODUCT MISUSE 10 0.0001
471 BLOOD CALCIUM INCREASED 1 0.0001
472 GASTROINTESTINAL INFECTION 1 0.0001
473 DRY MOUTH 9 0.0001
474 LEUKOCYTOSIS 2 0.0001
475 OSTEOMYELITIS 2 0.0001
476 DRUG EFFECT INCOMPLETE 4 0.0001
477 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
478 SUICIDAL IDEATION 10 0.0001
479 DYSURIA 4 0.0001
480 HEADACHE 68 0.0001
481 PERSONALITY CHANGE 1 0.0001
482 WOUND 3 0.0001
483 ABDOMINAL DISCOMFORT 18 0.0001
484 MIDDLE INSOMNIA 2 0.0001
485 DEFORMITY 1 0.0001
486 FLANK PAIN 1 0.0001
487 DYSPNOEA EXERTIONAL 4 0.0001
488 PRODUCT PACKAGING ISSUE 1 0.0001
489 INTENTIONAL DOSE OMISSION 3 0.0001
490 HYPERSOMNIA 3 0.0001
491 LETHARGY 6 0.0001
492 PRESCRIBED OVERDOSE 2 0.0001
493 DYSTONIA 2 0.0001
494 DYSSTASIA 3 0.0001
495 VITAMIN D DEFICIENCY 1 0.0001
496 PHARYNGEAL SWELLING 1 0.0001
497 COELIAC DISEASE 1 0.0001
498 KNEE OPERATION 1 0.0001
499 BLADDER DISORDER 1 0.0001
500 UPPER LIMB FRACTURE 2 0.0001
501 HYPOTONIA 1 0.0001
502 SALIVARY HYPERSECRETION 1 0.0001
503 BRAIN INJURY 1 0.0001
504 PREMATURE BABY 3 0.0001
505 APHASIA 3 0.0001
506 SOMNOLENCE 20 0.0001
507 PRODUCT ADMINISTRATION ERROR 2 0.0001
508 EXTRA DOSE ADMINISTERED 4 0.0001
509 FEEDING DISORDER 2 0.0001
510 DRUG LEVEL DECREASED 1 0.0001
511 INSOMNIA 26 0.0001
512 EAR DISCOMFORT 1 0.0001
513 CARDIAC ARREST 8 0.0001
514 INFLAMMATION 5 0.0001
515 POOR VENOUS ACCESS 1 0.0001
516 FEELING ABNORMAL 23 0.0001
517 TRANSFUSION 1 0.0001
518 MOUTH ULCERATION 2 0.0001
519 DRUG INTERACTION 15 0.0001
520 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
521 JOINT INJURY 2 0.0001
522 NIGHT SWEATS 3 0.0001
523 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
524 GASTROINTESTINAL PAIN 1 0.0001
525 FOOT DEFORMITY 1 0.0001
526 TACHYCARDIA 8 0.0001
527 GLOSSODYNIA 2 0.0001
528 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
529 THROAT IRRITATION 4 0.0001
530 THERAPY NON-RESPONDER 4 0.0001
531 IMPAIRED DRIVING ABILITY 1 0.0001
532 DERMATITIS CONTACT 1 0.0001
533 SCAB 1 0.0001
534 CAESAREAN SECTION 1 0.0001
535 VASCULITIS 1 0.0001
536 HYPOXIA 3 0.0001
537 INFLUENZA LIKE ILLNESS 7 0.0001
538 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
539 MUSCLE RIGIDITY 1 0.0001
540 MENTAL IMPAIRMENT 2 0.0001
541 ADRENAL INSUFFICIENCY 1 0.0001
542 PANIC ATTACK 3 0.0001
543 HEART RATE INCREASED 8 0.0001
544 POISONING 1 0.0001
545 HYPOPHAGIA 2 0.0001
546 LOSS OF CONSCIOUSNESS 10 0.0001
547 ADVERSE DRUG REACTION 7 0.0001
548 NERVOUSNESS 4 0.0001
549 MYALGIA 13 0.0001
550 INCORRECT PRODUCT STORAGE 1 0.0001
551 GASTRITIS 2 0.0001
552 ADVERSE EVENT 7 0.0001
553 ORAL CANDIDIASIS 1 0.0001
554 DEPRESSED MOOD 4 0.0001
555 ADVERSE REACTION 1 0.0001
556 MALAISE 33 0.0001
557 INCORRECT DOSE ADMINISTERED 17 0.0001
558 PAIN OF SKIN 2 0.0001
559 DISTURBANCE IN ATTENTION 4 0.0001
560 SINUS CONGESTION 1 0.0001
561 OEDEMA 4 0.0001
562 MOOD ALTERED 2 0.0001
563 AKATHISIA 1 0.0001
564 GINGIVAL BLEEDING 1 0.0001
565 DEPENDENCE 4 0.0001
566 HUNGER 1 0.0001
567 COORDINATION ABNORMAL 1 0.0001
568 BURNING SENSATION 5 0.0001
569 BLOOD TEST ABNORMAL 1 0.0001
570 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
571 FLATULENCE 4 0.0001
572 DIZZINESS 35 0.0001
573 THERAPY INTERRUPTED 5 0.0001
574 SYNCOPE 7 0.0001
575 BALANCE DISORDER 6 0.0001
576 SEIZURE 8 0.0001
577 MENTAL DISORDER 3 0.0001
578 HYPOKINESIA 1 0.0001
579 SURGERY 4 0.0001
580 ACUTE MYOCARDIAL INFARCTION 2 0.0001
581 URINARY INCONTINENCE 2 0.0001
582 DYSGEUSIA 5 0.0001
583 HAEMORRHAGE INTRACRANIAL 1 0.0001
584 EPISTAXIS 5 0.0001
585 BONE LOSS 1 0.0001
586 HOT FLUSH 5 0.0001
587 HYPOAESTHESIA ORAL 1 0.0001
588 DEPRESSION 15 0.0001
589 VISION BLURRED 9 0.0001
590 MUSCLE SPASMS 12 0.0001
591 DEVICE ADHESION ISSUE 1 0.0001
592 HYPOKALAEMIA 3 0.0001
593 MUSCULOSKELETAL CHEST PAIN 1 0.0001
594 COGNITIVE DISORDER 3 0.0001
595 PAIN 39 0.0001
596 DISEASE RECURRENCE 3 0.0001
597 HALLUCINATION, AUDITORY 1 0.0001
598 MOOD SWINGS 2 0.0001
599 ABSCESS 1 0.0001
600 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
601 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
602 CONFUSIONAL STATE 10 0.0001
603 BACK DISORDER 1 0.0001
604 PRODUCT DOSE OMISSION ISSUE 18 0.0001
605 PHOTOSENSITIVITY REACTION 1 0.0001
606 LIP SWELLING 2 0.0001
607 URINARY RETENTION 2 0.0001
608 BLOOD UREA INCREASED 1 0.0001
609 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
610 FACE OEDEMA 1 0.0001
611 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
612 ACUTE KIDNEY INJURY 9 0.0001
613 CHEST DISCOMFORT 6 0.0001
614 THERAPY CESSATION 3 0.0001
615 NIGHTMARE 2 0.0001
616 HEART RATE DECREASED 2 0.0001
617 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
618 DRUG EFFECT DECREASED 3 0.0001
619 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
620 GASTROENTERITIS VIRAL 1 0.0001
621 CONSTIPATION 12 0.0001
622 DRUG INEFFECTIVE 72 0.0001
623 BLOOD GLUCOSE ABNORMAL 1 0.0001
624 MEDICATION ERROR 3 0.0001
625 NECK PAIN 3 0.0001
626 HEPATIC FUNCTION ABNORMAL 2 0.0001
627 BLISTER 3 0.0001
628 FOOT FRACTURE 1 0.0001
629 BLOOD URINE PRESENT 1 0.0001
630 PERIPHERAL SWELLING 8 0.0001
631 EAR PAIN 1 0.0001
632 PALPITATIONS 6 0.0001
633 SKIN FISSURES 1 0.0001
634 KIDNEY INFECTION 1 0.0001
635 DYSPEPSIA 5 0.0001
636 DISABILITY 1 0.0001
637 ASTHENIA 19 0.0001
638 FLUSHING 5 0.0000
639 RIB FRACTURE 1 0.0000
640 HYPERSENSITIVITY 9 0.0000
641 PRODUCT USE ISSUE 9 0.0000
642 HYPERTENSION 10 0.0000
643 EATING DISORDER 1 0.0000
644 FAECES DISCOLOURED 1 0.0000
645 DEVICE DISLOCATION 2 0.0000
646 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
647 OFF LABEL USE 40 0.0000
648 PULMONARY OEDEMA 2 0.0000
649 WEIGHT INCREASED 10 0.0000
650 PRODUCT AVAILABILITY ISSUE 1 0.0000
651 ABDOMINAL PAIN UPPER 9 0.0000
652 NEPHROLITHIASIS 2 0.0000
653 TINNITUS 2 0.0000
654 SKIN DISCOLOURATION 2 0.0000
655 OROPHARYNGEAL PAIN 4 0.0000
656 CHEST PAIN 8 0.0000
657 DECREASED APPETITE 10 0.0000
658 RENAL DISORDER 2 0.0000
659 SWELLING 4 0.0000
660 SLEEP DISORDER 3 0.0000
661 PRODUCT PRESCRIBING ERROR 1 0.0000
662 MIGRAINE 4 0.0000
663 BLOOD PRESSURE FLUCTUATION 1 0.0000
664 EMOTIONAL DISTRESS 5 0.0000
665 LUNG DISORDER 2 0.0000
666 PAIN IN EXTREMITY 12 0.0000
667 ENCEPHALOPATHY 1 0.0000
668 AGEUSIA 1 0.0000
669 PNEUMONIA ASPIRATION 1 0.0000
670 AGGRESSION 2 0.0000
671 HALLUCINATION 3 0.0000
672 CELLULITIS 2 0.0000
673 ABDOMINAL PAIN LOWER 1 0.0000
674 HAEMATEMESIS 1 0.0000
675 SINUSITIS 4 0.0000
676 ERECTILE DYSFUNCTION 1 0.0000
677 DYSPNOEA 22 0.0000
678 BACK PAIN 9 0.0000
679 RESPIRATORY TRACT INFECTION 1 0.0000
680 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
681 DEAFNESS 1 0.0000
682 SEDATION 1 0.0000
683 PANCREATITIS 2 0.0000
684 EAR INFECTION 1 0.0000
685 DEHYDRATION 5 0.0000
686 FEAR 1 0.0000
687 THROAT TIGHTNESS 1 0.0000
688 LIMB INJURY 1 0.0000
689 PALLOR 1 0.0000
690 TREATMENT NONCOMPLIANCE 2 0.0000
691 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
692 ABNORMAL DREAMS 1 0.0000
693 HAEMOPTYSIS 1 0.0000
694 PANCYTOPENIA 2 0.0000
695 OXYGEN SATURATION DECREASED 2 0.0000
696 EYE PAIN 2 0.0000
697 TARDIVE DYSKINESIA 1 0.0000
698 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
699 PAIN IN JAW 1 0.0000
700 CONVULSION 2 0.0000
701 EYE IRRITATION 2 0.0000
702 INFECTION 5 0.0000
703 DYSPHONIA 2 0.0000
704 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
705 LABORATORY TEST ABNORMAL 1 0.0000
706 RENAL INJURY 1 0.0000
707 HEPATIC FAILURE 1 0.0000
708 LACRIMATION INCREASED 1 0.0000
709 ILL-DEFINED DISORDER 2 0.0000
710 CONDITION AGGRAVATED 10 0.0000
711 DISCOMFORT 2 0.0000
712 BLOOD PRESSURE INCREASED 5 0.0000
713 FEELING HOT 2 0.0000
714 INJECTION SITE RASH 1 0.0000
715 HOSPITALISATION 5 0.0000
716 EMOTIONAL DISORDER 1 0.0000
717 LIMB DISCOMFORT 1 0.0000
718 WEIGHT DECREASED 9 0.0000
719 NERVOUS SYSTEM DISORDER 1 0.0000
720 HEAD INJURY 1 0.0000
721 NEUROPATHY PERIPHERAL 3 0.0000
722 METABOLIC ACIDOSIS 1 0.0000
723 INTENTIONAL OVERDOSE 2 0.0000
724 MOVEMENT DISORDER 1 0.0000
725 DIARRHOEA 20 0.0000
726 AMNESIA 2 0.0000
727 SWELLING FACE 2 0.0000
728 CHOLELITHIASIS 1 0.0000
729 STAPHYLOCOCCAL INFECTION 1 0.0000
730 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
731 BLOOD PRESSURE DECREASED 2 0.0000
732 VIRAL INFECTION 1 0.0000
733 FALL 10 0.0000
734 SKIN DISORDER 1 0.0000
735 DRY SKIN 4 0.0000
736 NEOPLASM MALIGNANT 2 0.0000
737 EYE PRURITUS 1 0.0000
738 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
739 HAEMATURIA 1 0.0000
740 GASTRIC DISORDER 1 0.0000
741 PYREXIA 10 0.0000
742 DEVICE USE ERROR 1 0.0000
743 ABDOMINAL DISTENSION 3 0.0000
744 COVID-19 5 0.0000
745 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
746 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
747 PRODUCT ADHESION ISSUE 1 0.0000
748 PNEUMONIA 9 0.0000
749 MYELOSUPPRESSION 1 0.0000
750 CRYING 1 0.0000
751 C-REACTIVE PROTEIN INCREASED 1 0.0000
752 RESPIRATORY FAILURE 2 0.0000
753 FATIGUE 21 0.0000
754 HYPOAESTHESIA 4 0.0000
755 DYSARTHRIA 1 0.0000
756 ARTHRALGIA 11 0.0000
757 UNEVALUABLE EVENT 2 0.0000
758 RHEUMATOID ARTHRITIS 3 0.0000
759 CHRONIC KIDNEY DISEASE 2 0.0000
760 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
761 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
762 ABDOMINAL PAIN 6 0.0000
763 ABNORMAL BEHAVIOUR 1 0.0000
764 DISORIENTATION 1 0.0000
765 RASH 11 0.0000
766 HYPOTENSION 5 0.0000
767 PSORIATIC ARTHROPATHY 1 0.0000
768 OEDEMA PERIPHERAL 3 0.0000
769 BLINDNESS 1 0.0000
770 LUNG NEOPLASM MALIGNANT 1 0.0000
771 URTICARIA 4 0.0000
772 RENAL IMPAIRMENT 2 0.0000
773 SKIN EXFOLIATION 2 0.0000
774 PRURITUS 9 0.0000
775 DEVICE LEAKAGE 1 0.0000
776 ANGIOEDEMA 1 0.0000
777 LIVER DISORDER 1 0.0000
778 SKIN IRRITATION 1 0.0000
779 CARDIAC DISORDER 2 0.0000
780 OCULAR HYPERAEMIA 1 0.0000
781 DYSPHAGIA 2 0.0000
782 COMA 1 0.0000
783 ANAEMIA 4 0.0000
784 PRODUCTIVE COUGH 1 0.0000
785 GAIT DISTURBANCE 4 0.0000
786 CONTUSION 2 0.0000
787 HYPOGLYCAEMIA 1 0.0000
788 ALOPECIA 4 0.0000
789 FLUID RETENTION 1 0.0000
790 ECZEMA 1 0.0000
791 SPEECH DISORDER 1 0.0000
792 PARAESTHESIA 3 0.0000
793 DERMATITIS ATOPIC 1 0.0000
794 BRADYCARDIA 1 0.0000
795 PLATELET COUNT DECREASED 2 0.0000
796 RASH PRURITIC 1 0.0000
797 HAEMATOCHEZIA 1 0.0000
798 INFLUENZA 2 0.0000
799 SEPSIS 2 0.0000
800 COUGH 5 0.0000
801 HYPONATRAEMIA 1 0.0000
802 ASTHMA 2 0.0000
803 URINARY TRACT INFECTION 3 0.0000
804 HERPES ZOSTER 1 0.0000
805 NASAL CONGESTION 1 0.0000
806 CATARACT 1 0.0000
807 JOINT SWELLING 2 0.0000
808 SUICIDE ATTEMPT 1 0.0000
809 PLEURAL EFFUSION 1 0.0000
810 VERTIGO 1 0.0000
811 VISUAL IMPAIRMENT 2 0.0000
812 INJECTION SITE ERYTHEMA 2 0.0000
813 INFUSION RELATED REACTION 1 0.0000
814 FEBRILE NEUTROPENIA 1 0.0000
815 NEUTROPENIA 2 0.0000
816 HEPATIC ENZYME INCREASED 1 0.0000
817 INJURY 1 0.0000
818 DEATH 12 0.0000
819 MOBILITY DECREASED 1 0.0000
820 UNDERDOSE 1 0.0000
821 BRONCHITIS 1 0.0000
822 INJECTION SITE SWELLING 1 0.0000
823 ARTHRITIS 1 0.0000
824 CARDIAC FAILURE 1 0.0000
825 CARDIAC FAILURE CONGESTIVE 1 0.0000
826 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
827 CEREBROVASCULAR ACCIDENT 2 0.0000
828 MYOCARDIAL INFARCTION 2 0.0000
829 PRODUCT STORAGE ERROR 1 0.0000
830 MUSCULOSKELETAL STIFFNESS 1 0.0000
831 DEVICE ISSUE 1 0.0000
832 NASOPHARYNGITIS 2 0.0000
833 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
834 MUSCULAR WEAKNESS 1 0.0000
835 PSORIASIS 1 0.0000
836 RENAL FAILURE 1 0.0000
837 MEMORY IMPAIRMENT 1 0.0000
838 INJECTION SITE PAIN 2 0.0000
839 DRUG DOSE OMISSION 1 0.0000
840 NO ADVERSE EVENT 1 0.0000
841 BLOOD GLUCOSE INCREASED 1 0.0000
842 ERYTHEMA 1 0.0000